NO951163L - Metode for antagonisering av inositol-1,4,5-trifosfat - Google Patents

Metode for antagonisering av inositol-1,4,5-trifosfat

Info

Publication number: NO951163L
Authority: NO; Norway
Prior art keywords: antagonizing; inositol; triphosphate; oligomers; oligomer
Prior art date: 1992-09-28

Application number

NO951163A

Other languages

English (en)

Norwegian (no)

Other versions

NO951163D0 (no

Inventor

Kenneth A Stauderman

Original Assignee

Merrell Dow Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-28

Filing date

1995-03-27

Publication date

1995-03-27

1995-03-27 Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma

1995-03-27 Publication of NO951163L publication Critical patent/NO951163L/no

1995-03-27 Publication of NO951163D0 publication Critical patent/NO951163D0/no

Links

MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 title 1
230000003042 antagnostic effect Effects 0.000 title 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
229910052791 calcium Inorganic materials 0.000 abstract 1
239000011575 calcium Substances 0.000 abstract 1
230000006957 competitive inhibition Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000003834 intracellular effect Effects 0.000 abstract 1
230000001766 physiological effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Polyurethanes Or Polyureas (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO951163A 1992-09-28 1995-03-27 Metode for antagonisering av inositol-1,4,5-trifosfat NO951163D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US95239392A	1992-09-28	1992-09-28
PCT/US1993/008168 WO1994007507A1 (en)	1992-09-28	1993-08-30	Method for antagonizing inositol 1,4,5-triphosphate

Publications (2)

Publication Number	Publication Date
NO951163L true NO951163L (no)	1995-03-27
NO951163D0 NO951163D0 (no)	1995-03-27

Family

ID=25492868

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO951163A NO951163D0 (no)	1992-09-28	1995-03-27	Metode for antagonisering av inositol-1,4,5-trifosfat

Country Status (13)

Country	Link
EP (1)	EP0661982A1 (it)
JP (1)	JPH08502068A (it)
KR (1)	KR950703347A (it)
AU (1)	AU670962B2 (it)
CA (1)	CA2145681A1 (it)
HU (1)	HUT70192A (it)
IL (1)	IL107066A (it)
MX (1)	MX9305933A (it)
NO (1)	NO951163D0 (it)
NZ (1)	NZ256178A (it)
TW (1)	TW260663B (it)
WO (1)	WO1994007507A1 (it)
ZA (1)	ZA936978B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996000586A2 (en) *	1994-06-30	1996-01-11	MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.	Methods for treating cell proliferative disorders by modulating signal transduction
EP0809492A4 (en)	1995-02-17	2007-01-24	Smithkline Beecham Corp	IL-8 RECEPTOR ANTAGONISTS
US5780483A (en) *	1995-02-17	1998-07-14	Smithkline Beecham Corporation	IL-8 receptor antagonists
US6083920A (en) *	1995-12-21	2000-07-04	Ayurcore, Inc.	Compositions for modulating intracellular inositol trisphosphate concentration
US6005008A (en) *	1996-02-16	1999-12-21	Smithkline Beecham Corporation	IL-8 receptor antagonists
US6211373B1 (en)	1996-03-20	2001-04-03	Smithkline Beecham Corporation	Phenyl urea antagonists of the IL-8 receptor
US6262113B1 (en)	1996-03-20	2001-07-17	Smithkline Beecham Corporation	IL-8 receptor antagonists
PL330850A1 (en) *	1996-06-27	1999-06-07	Smithkline Beecham Corp	Antagonists of il-8 receptors
PL330849A1 (en)	1996-06-27	1999-06-07	Smithkline Beecham Corp	Antagonists of il-8 receptors
EP1331932B1 (en) *	2000-11-09	2007-04-04	Contrimmune Biotechnology Inc.	Use of xestospongin c for treating or preventing hiv infection
BR112014005104A2 (pt)	2011-09-02	2017-07-04	Salk Inst For Biological Studi	inibidores camkii, ip3r, calcineurin, p38 e mk2/3 para tratar atar distúrbios metabólicos de obesidade

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB781479A (en) *	1953-08-27	1957-08-21	Ciba Ltd	New polyureas and process for making them
US5276182A (en) *	1990-07-09	1994-01-04	The Dow Chemical Company	Process for preparing polyurea oligomers

1993
- 1993-08-30 KR KR1019950701166A patent/KR950703347A/ko not_active Ceased
- 1993-08-30 WO PCT/US1993/008168 patent/WO1994007507A1/en not_active Ceased
- 1993-08-30 CA CA002145681A patent/CA2145681A1/en not_active Abandoned
- 1993-08-30 AU AU48417/93A patent/AU670962B2/en not_active Ceased
- 1993-08-30 NZ NZ256178A patent/NZ256178A/en unknown
- 1993-08-30 EP EP93921252A patent/EP0661982A1/en not_active Ceased
- 1993-08-30 HU HU9500891A patent/HUT70192A/hu unknown
- 1993-08-30 JP JP6509054A patent/JPH08502068A/ja active Pending
- 1993-09-21 ZA ZA936978A patent/ZA936978B/xx unknown
- 1993-09-22 TW TW082107787A patent/TW260663B/zh active
- 1993-09-22 IL IL107066A patent/IL107066A/en not_active IP Right Cessation
- 1993-09-27 MX MX9305933A patent/MX9305933A/es unknown
1995
- 1995-03-27 NO NO951163A patent/NO951163D0/no unknown

Also Published As

Publication number	Publication date
AU670962B2 (en)	1996-08-08
NZ256178A (en)	1997-03-24
CA2145681A1 (en)	1994-04-14
ZA936978B (en)	1994-04-18
JPH08502068A (ja)	1996-03-05
HU9500891D0 (en)	1995-05-29
AU4841793A (en)	1994-04-26
NO951163D0 (no)	1995-03-27
KR950703347A (ko)	1995-09-20
HUT70192A (en)	1995-09-28
WO1994007507A1 (en)	1994-04-14
IL107066A0 (en)	1993-12-28
EP0661982A1 (en)	1995-07-12
TW260663B (it)	1995-10-21
IL107066A (en)	1998-01-04
MX9305933A (es)	1994-04-29

Similar Documents

Publication	Publication Date	Title
UA26213C2 (uk)	1999-07-19	Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
HUT62337A (en)	1993-04-28	New cyclosporins, pharmaceutical compositions comprising such compounds and process for producing same
AU1876788A (en)	1989-01-12	Methylene phosphonoalkylphosphinates, pharmaceutical compositions , and methods for treating abnormal calcium and phosphate metabolism
HU912359D0 (en)	1991-12-30	The use of flupirtine active agents for treating muscle-tension
EP0363415A4 (en)	1993-03-17	Compounds for the treatment of alzheimer's disease
EP0807633A3 (en)	1998-05-13	Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
NO952890D0 (no)	1995-07-20	Kombinasjonsbehandling for inhibisjon av bentap
HU910930D0 (en)	1991-10-28	Process for the production of 2,8-dioxa-bicyclo/3.2.1/octane derivatives and medical preparations containing them
GR3023457T3 (en)	1997-08-29	Inhibitors of hiv protease useful for the treatment of aids.
NO902800L (no)	1990-12-27	Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
DE59204024D1 (de)	1995-11-23	Verwendung von sulfatierten Oligosacchariden zur Behandlung arteriosklerotischer Erkrankungen und zur Verhinderung der Restenosierung.
DK0701546T3 (da)	1999-08-16	Aromatiske acetylchlolinesteraseinhibitorer
FI102896B1 (fi)	1999-03-15	Menetelmä farmaseuttisesti aktiivisen, rikkiä sisältävän heterosyklisen yhdisteen valmistamiseksi
ZA887399B (en)	1990-05-30	4-aminopyridine derivatives
EP0328634A4 (en)	1991-08-21	Pharmaceutical compositions for the treatment of psoriasis
MX9305933A (es)	1994-04-29	Metodo para antagonizar al 1,4,5-trifosfato de inositol.
EP0305181A3 (en)	1990-08-22	Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin
TW325997B (en)	1998-02-01	Pharmaceutical composition for preventing and treating retinal diseases
IL88740A0 (en)	1989-07-31	Compositions for the inhibition of viruses
HUT70757A (en)	1995-10-30	Pharmaceutical compositions for treating skin disorders
GR3034161T3 (en)	2000-11-30	Pharmaceutical composition for preventing or treating.
HUT55994A (en)	1991-07-29	Process for producing pharmaceutical compositions for producing or inhibiting contraction of the pupil
ATE88634T1 (de)	1993-05-15	Arzneimittel zur behandlung von herzinsuffizienz.
NO911237D0 (no)	1991-03-26	Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og -kinolizidiner.
ATE113843T1 (de)	1994-11-15	Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.